CliffBio

Rigel Pharmaceuticals

Patent cliffs & loss of exclusivity

Small Molecules

Company

AngelList URLhttps://angel.co/rigel-pharmaceuticals-3/
Business ModelCommerce
CAGE Code60TS7
Legal NameRigel Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/rigel-pharmaceuticals/
Email format{last}
Facebook URLhttps://www.facebook.com/pages/Rigel-Pharmaceuticals/108117435876132

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. TAVALISSEFOSTAMATINIB DISODIUMSmall mol.Jul 2032
  2. TAVALISSEFOSTAMATINIB DISODIUMSmall mol.Jul 2032
  3. REZLIDHIAOLUTASIDENIBSmall mol.Nov 2039
  4. GAVRETOPRALSETINIBSmall mol.Apr 2043

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.